Pasithea Therapeutics Cor... (KTTAW)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue - 486.56K 15.06K -
Cost of Revenue 648.45K 113.19K 17.27K -
Gross Profit -648.45K 373.36K -2.21K -
Operating Income -15.98M -14.82M -4.51M -40.98K
Interest Income - 102.00 508.00 -
Pretax Income -15.51M -13.94M -2.17M -40.98K
Net Income -15.96M -13.06M -2.17M -40.98K
Selling & General & Admin 7.88M 12.52M 4.51M 40.98K
Research & Development 8.10M 2.67M - -
Other Expenses - 44.72K - -
Operating Expenses 15.98M 15.19M 4.51M 40.98K
Interest Expense - 102.00 508.00 -
Selling & Marketing Expenses -7.87B 2.60M - -
Cost & Expenses 15.98M 15.30M 4.52M 40.98K
Income Tax - -879.97K 508.00 -61.48K
Shares Outstanding (Basic) 1.26M 1.26M 1.15M 688.92K
Shares Outstanding (Diluted) 1.23M 1.26M 1.15M 688.92K
EPS (Basic) -12.65 -10.34 -1.89 -0.06
EPS (Diluted) -13.01 -10.34 -1.89 -0.06
EBITDA -15.33M -12.58M -4.51M -
Depreciation & Amortization 648.45K 5.09K 1.38K 61.48K